Effective and Practical Ways to Impact Health Inequity Now

A guide to asking the right health equity questions to influence market access strategies

New whitepaper from Archbow Consulting, Entrée Health, and Valuate Health Consultancy is available for download now.

e41585_40802d1a603244bb863550db279feafa~mv2

Effective and Practical Ways to Impact Health Inequity Now: A guide to asking the right health equity questions to influence market access strategies

As advisors to organizations in the biopharmaceutical space, we’re trusted with closely monitoring trends that influence how healthcare may or may not be accessed. Of late, one trend is garnering more scrutiny than others—health equity.

Many of our clients have instituted new health equity goals and initiatives. That’s excellent news; except that more than a few market access teams are scratching their heads about how they can solve a problem that leading healthcare organizations around the world are struggling to meaningfully impact.

That’s why we pulled together our experts to write a whitepaper identifying practical ways that market access teams can decrease health inequity within their spheres of influence.

As with most good solutions, making strides in equalizing opportunities for good health starts with asking the right questions. This whitepaper provides practical lists of questions spanning distribution, access, and affordability that market access teams can use to begin impacting health equity today.

The Effective and Practical Ways to Impact Health Inequity Now whitepaper includes:

An overview and background of the health equity landscape
Essential questions to ask across:
- Prevention methods
- Dispensing strategies
- Food insecurity and financial toxicity
- Patient support program design
- Patient support program communications
- Medical mistrust
- Healthcare data modeling

The whitepaper is available for free download now.

Health inequity is a large, global issue that none of us can solve on our own, but each of us can impact through our individual roles. By asking the right questions, market access teams can start identifying ways to make significant differences in the lives of the patient populations they’re committed to serving.

Our teams are actively engaging with our clients daily to workshop health equity concerns, create and refine strategies to address the most pressing issues, and proactively design future programs to identify and eliminate barriers that may have previously gone unrecognized. Contact us today if our learnings in this space can be of help to your team.

For additional insights on this topic, you may also enjoy the following:

11 Market Access Questions to Address Prior to Launching Your First Specialty Drug

A Total Solution to Your Market Access Needs

Understanding Pharmaceutical Market Access Differences in the US and Europe

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.

Share in